CaPPRe was commissioned by Janssen to conduct a traetment preference study for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis patients. The poster is presented at the 21st Asia Pacific League of Associations for Rheumatology Congress. Click here for the poster.
CaPPRe has published a peer-reveiwed research paper on patient preferences for type 2 diabetes treatments. Using discrete choice experiment methodology, the findings showed that patients considered injection frequency, weight change and nausea to be important features of treatment. Patients were wiling to pay an additional $22.35 UAD/month for the benefits of a once-weekly injection over a twice-daily injection.
The paper is published in the open-access journal BMC Health Services... Read more
In August 2017, we conducted a community value mapping study in 500 consumers who had visited a pharmacy in the last 3 months. Participants were asked to evaluate their preferences for pharmacies offering different locations, opening hours, sevrices and cost. Results showed that there were 3 segments of consumers; those that were service driven, those that were access driven and those that were driven by loyalty. For more infromation about the study and our findings, see... Read more
In December 2017 we conducted a pilot study to understand parents'/caregivers' preferences for school canteen menus. We surveyed 416 parents/caregivers in NSW with at least one child in primary school. We presented the findings at an invitation-only economics conference with NSW Government in January 2018. To see the findings, see our infographic or ... Read more
In August 2017 we conducted a pilot study to understand the community's preferences for genetic testing. We surveyed a representative sample of 500 people across Australia and asked them to evaulate different options for genetic testing in areas of cancer, arthritis, Alzheimer's disease, bipolar disorder and multiple sclerosis. Overall, 9 in 10 people said that they would do a genetic test to find out their risk factors for certain diseases.... Read more
Non-market valuation involves valuing the benefits of projects / policies which are not directly traded in markets (e.g., environment, government infrastructure, public health interventions etc.)
Examples of non-market projects include:
- The value to the community of upgrades to the Opera House
- The value to the community of new developments / attractions in regional NSW
- The value to the community of conserving environmental areas
We work closely with... Read more
Incorporating the patient perspective on the value of medicines into health technology assessments is becoming increasingly more important as acknowledged by several prominent HTA agencies. NICE in the UK has employed several measures, including a Citizen’s Council. Canada, particularly in the area of oncology, has a formalized process through which patient input on drug reviews and feedback on recommendations is obtained to ensure patients’ experiences (both good and bad)... Read more